Cairo University: Vitiligo trials

The registry lists 25 Vitiligo studies with Cairo University as lead sponsor. 6 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 1Phase 4 4No phase 19(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Gingival Hyperpigmentation TreatmentRecruitingNCT07595705Phase 2
• The Value of Adding Mini-oral Pulse Steroid Therapy in Preventing Peri-lesional Halo Post Non-cultured Epidermal Cell Suspension (NCES) in Cases With Stable Segmental and Non-acral Vitiligo.Not yet recruitingNCT07472816Phase 4
• Betamethasone Phonophoresis For VitiligoRecruitingNCT07267273Not applicable
• The Value of Using Mini-oral Pulse Steroid Therapy Along With Non Cultured Epidermal Cell Suspension (NCES) in Stable Resistant VitiligoNot yet recruitingNCT06974669Not applicable
• IL35 Level in VitiligoNot yet recruitingNCT05980390
• Insulin Like Growth Factor-1 Against Oxidative Stress in VitiligoNot yet recruitingNCT05812079
• Oral Mini Pulse Dexamethasone in Pediatric VitiligoCompletedNCT07353801Phase 4
• The Value of Methotrexate in NCES for Stable VitiligoCompletedNCT07352293Phase 4
• A Comparative Study on the Efficacy of Blue Light Emitting Diodes Therapy Versus Targeted Narrow Band UVB in Stable Non-segmental Vitiligo Patients.CompletedNCT07174024Phase 4
• T Central Memory Cells in Early Localized Non-Segmental VitiligoCompletedNCT05706636Not applicable
• Autologous Cellular Graft in Surgical Treatment of VitiligoSuspendedNCT05503368Not applicable
• Sensory Symptoms in Active VitiligoStatus unknownNCT05390164
• Effect of NB-UVB on the Tissue Level of IL 15 and IL-15Rα in Active Non Segmental Vitiligo Cases.CompletedNCT05316987Not applicable
• Effect of Early Systemic Stabilization Therapy on Recent Onset VitiligoCompletedNCT05037981
• Combined Effect of Acitretin and Narrow Band Ultraviolet B on Vitiligo RepigmentationStatus unknownNCT04245319Not applicable
• Human Beta-defensin 1 in VitiligoStatus unknownNCT03832751Not applicable
• Janus Kinase 1 in Vitiligo & PsoriasisCompletedNCT03762551Not applicable
• Prostaglandin F2-alpha (PGF2α) in VitiligoStatus unknownNCT03755830Not applicable
• Metabolic Syndrome in Early Onset Versus Late Onset VitiligoCompletedNCT03622320
• Vitiligo Extent Score (VES) Score in Comparison to Vitiligo Area and Severity Index (VASI) ScoreCompletedNCT03411135
• Leucotrichia in VitiligoCompletedNCT03402633
• UVA1 Phototherapy in Acral VitiligoCompletedNCT03378011Not applicable
• Expression of LC3-I, LC3-II & Beclin 1 in VitiligoStatus unknownNCT03371758Not applicable
• Thymic Stromal Lymphopoietin (TSLP) in VitiligoCompletedNCT03367273Not applicable
• Effect of Procedural Variables on Outcome of Surgical Treatment of VitiligoCompletedNCT02510651Phase 1